Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Montreal researchers identifies two specific key players in growth of GBM

Glioblastoma (GBM) is the most common and deadly form of primary malignant brain cancer accounting for approximately 15% of all brain tumours and occurring mostly in adults between the ages of 45 and 70.

9 Jan 2014

Epilepsy drug taken during pregnancy not linked with development problems for preschoolers

A new study finds that the epilepsy drug levetiracetam appears not to be associated with thinking, movement and language problems for preschool children born to mothers who took the drug during pregnancy, although the drug valproate was associated with some difficulties in preschoolers.

8 Jan 2014

Apitope-led consortium awarded FP7 Health Innovation funding to develop Graves' disease vaccine

Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announces that the consortium, led by Apitope, which includes GSK Vaccines, Quintiles and KWS Biotest Limited, has been awarded prestigious Framework Programme 7 Health Innovation funding by the European Commission to develop its Graves' disease therapeutic vaccine, including a Phase I first-in-man study in Graves' disease patients.

8 Jan 2014

IQWiG study finds no added benefit of teriflunomide

Teriflunomide (trade name: Aubagio) has been approved in Germany since August 2013 for adults with relapsing remitting multiple sclerosis. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the appropriate comparator therapy specified by the Federal Joint Committee (G-BA).

8 Jan 2014

How Obamacare coverage is shaking out

Even with the health law's insurance options, consumers struggling with chronic diseases may still face such high out-of-pocket costs on some plans that they could have trouble staying out of debt, reports the Associated Press. Meanwhile, several major drugstore chains are offering to fill prescriptions for those who enrolled in new health plans but don't have ID numbers yet.

6 Jan 2014

LA BioMed receives grant to study role of serum Vitamin A in people with multiple sclerosis

Some 2.5 million people around the world have multiple sclerosis (MS), a potentially debilitating disease in which the body's immune system destroys the protective sheath (myelin) that covers nerves.

6 Jan 2014

First Edition: January 6, 2014

Today's headlines include reports about how the health law fits into the Capitol Hill agenda for the year ahead.

6 Jan 2014

Shingles may increase risk of stroke in later life, study finds

Having shingles may increase the risk of having a stroke years later, according to research published in the January 2, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

2 Jan 2014

Kessler Foundation to conduct pilot study on improving memory, function in MS patients

Kessler Foundation has been awarded a new grant by the National Multiple Sclerosis Society for a pilot study of memory and learning difficulties in individuals with MS. Scientists will test the effectiveness of using of self-generated learning in a treatment intervention to improve memory and functional performance.

1 Jan 2014

Genzyme gets FDA Complete Response Letter for Lemtrada sBLA

Genzyme, a Sanofi company, announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration for its supplemental Biologics License Application seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis.

30 Dec 2013

MitoQ antioxidant reverses MS-like disease in animal

Researchers at Oregon Health & Science University have discovered that an antioxidant designed more than a dozen years ago to fight damage within human cells significantly helps symptoms in mice that have a multiple sclerosis-like disease.

27 Dec 2013

Concussion involving momentary loss of consciousness may be related to buildup of Alzheimer's

A new study suggests that a history of concussion involving at least a momentary loss of consciousness may be related to the buildup of Alzheimer's-associated plaques in the brain.

27 Dec 2013

Researchers report new gene delivery method that targets tumor blood vessels

Working in mice, researchers at Washington University School of Medicine in St. Louis report developing a gene delivery method long sought in the field of gene therapy: a deactivated virus carrying a gene of interest that can be injected into the bloodstream and make its way to the right cells.

24 Dec 2013

ANP reports positive interim results from ATL1103 Phase II clinical trial for acromegaly

Antisense Therapeutics Limited is pleased to advise that positive results have been achieved from the interim analysis of a subset of available data from its Phase II clinical trial of ATL1103 in patients with the growth disorder, acromegaly.

23 Dec 2013

European Commission approves update of Erbitux to treat patients with RAS wild-type mCRC

Merck Serono, the biopharmaceutical division of Merck, today announced that the European Commission has approved the Type II variation to amend the Erbitux(cetuximab) product information, updating the indication for Erbitux to the treatment of patients with RAS wild-type metastatic colorectal cancer (mCRC).

23 Dec 2013

Kessler Foundation scientists awarded subcontract to study ways to improve disability statistics

Kessler Foundation scientists John O'Neill, PhD, CRC and Amanda Botticello, PhD, MPH, were awarded a subcontract on the University of New Hampshire's Rehabilitation Research and Training Center grant on Disability Statistics and Demographics. The five-year grant is funded by the National Institute on Disability and Rehabilitation Research under cooperative agreement H133B130015. Economist Andrew Houtenville, PhD, of UNH's Institute on Disability, is project director of the StatsRRTC grant, which totals $4.3 million.

22 Dec 2013

Six common diseases arise from DNA changes, finds new research

Many rare disorders are caused by gene mutation, like sickle cell anemia. Yet until now the underlying genetic cause of more common conditions - for example, rheumatoid arthritis - has evaded scientists for years.

22 Dec 2013

New MRI approach can be important tool for diagnosing, tracking MS progression

New imaging research from Western University (London, Canada) has demonstrated that a magnetic resonance imaging approach called quantitative susceptibility mapping can be an important tool for diagnosing and tracking the progression of Multiple Sclerosis and other neurological diseases.

20 Dec 2013

Australian Therapeutic Goods Administration approves Genzyme's Lemtrada for multiple sclerosis

Genzyme, a Sanofi company, announced today that the Australian Therapeutic Goods Administration has approved Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis for patients with active disease defined by clinical or imaging features to slow the accumulation of physical disability and reduce the frequency of clinical relapses.

19 Dec 2013

Viewpoints: New healthcare.gov czar knows something about computer bugs; fears about inadequate drug coverage

Seriously, one has to hope the new guy -- Kurt DelBene, former head of the Microsoft Office Division -- brings only a portion of Microsoft's heritage along with him. Aside from the XBox, the software giant isn't known for great consumer experiences. Its products have been maddeningly complex and notoriously buggy, at least in their early versions. Kind of like HealthCare.gov! (Jon Healey, 12/17).

19 Dec 2013

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Montreal researchers identifies two specific key players in growth of GBM

Epilepsy drug taken during pregnancy not linked with development problems for preschoolers

Apitope-led consortium awarded FP7 Health Innovation funding to develop Graves' disease vaccine

IQWiG study finds no added benefit of teriflunomide

How Obamacare coverage is shaking out

LA BioMed receives grant to study role of serum Vitamin A in people with multiple sclerosis

First Edition: January 6, 2014

Shingles may increase risk of stroke in later life, study finds

Kessler Foundation to conduct pilot study on improving memory, function in MS patients

Genzyme gets FDA Complete Response Letter for Lemtrada sBLA

MitoQ antioxidant reverses MS-like disease in animal

Concussion involving momentary loss of consciousness may be related to buildup of Alzheimer's

Researchers report new gene delivery method that targets tumor blood vessels

ANP reports positive interim results from ATL1103 Phase II clinical trial for acromegaly

European Commission approves update of Erbitux to treat patients with RAS wild-type mCRC

Kessler Foundation scientists awarded subcontract to study ways to improve disability statistics

Six common diseases arise from DNA changes, finds new research

New MRI approach can be important tool for diagnosing, tracking MS progression

Australian Therapeutic Goods Administration approves Genzyme's Lemtrada for multiple sclerosis

Viewpoints: New healthcare.gov czar knows something about computer bugs; fears about inadequate drug coverage

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in